The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer

Ki67 is a commonly used marker of cancer cell proliferation, and has significant prognostic value in breast cancer. In spite of its clinical importance, assessment of Ki67 remains a challenge, as current manual scoring methods have high inter- and intra-user variability. A major reason for this vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Satbir Singh, Li, Haocheng, Chan, Angela M. Y., Tudor, Roxana, Bigras, Gilbert, Morris, Don, Enwere, Emeka K., Yang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755729/
https://www.ncbi.nlm.nih.gov/pubmed/29304138
http://dx.doi.org/10.1371/journal.pone.0188983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755729/
https://www.ncbi.nlm.nih.gov/pubmed/29304138
http://dx.doi.org/10.1371/journal.pone.0188983

Ejemplares similares